Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2014 1
2017 2
2018 1
2019 1
2021 2
2022 3
2023 4
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean hasuike y[au] (206 results)?
Clinical Impact of Enhanced Recovery After Esophagectomy in Patients With Esophageal Cancer.
Sugase T, Kanemura T, Takeoka T, Urakawa S, Sugimura K, Masuike Y, Shinno N, Hara H, Omori T, Kitakaze M, Kubo M, Mukai Y, Sueda T, Hasegawa S, Akita H, Nishimura J, Wada H, Yasui M, Miyata H. Sugase T, et al. Among authors: masuike y. Anticancer Res. 2023 Sep;43(9):4197-4205. doi: 10.21873/anticanres.16611. Anticancer Res. 2023. PMID: 37648293
LIN28B induces a differentiation program through CDX2 in colon cancer.
Suzuki K, Masuike Y, Mizuno R, Sachdeva UM, Chatterji P, Andres SF, Sun W, Klein-Szanto AJ, Besharati S, Remotti HE, Verzi MP, Rustgi AK. Suzuki K, et al. Among authors: masuike y. JCI Insight. 2021 May 10;6(9):e140382. doi: 10.1172/jci.insight.140382. JCI Insight. 2021. PMID: 33755595 Free PMC article.
OSK-0028 in Patients With Esophageal Cancer Undergoing Esophagectomy: A Double-blind, Randomised Controlled Trial.
Yamashita K, Miyazaki Y, Nakatani D, Masuike Y, Tanaka K, Sugimura K, Makino T, Shiraishi O, Takahashi T, Kurokawa Y, Yamasaki M, Miyata H, Kimura Y, Araki H, Yamada T, Yasuda T, Yano M, Eguchi H, Doki Y. Yamashita K, et al. Among authors: masuike y. Anticancer Res. 2021 Aug;41(8):3875-3884. doi: 10.21873/anticanres.15182. Anticancer Res. 2021. PMID: 34281849 Clinical Trial.
Low mitochondrial DNA copy number induces chemotherapy resistance via epithelial-mesenchymal transition by DNA methylation in esophageal squamous cancer cells.
Kubo Y, Tanaka K, Masuike Y, Takahashi T, Yamashita K, Makino T, Saito T, Yamamoto K, Tsujimoto T, Harino T, Kurokawa Y, Yamasaki M, Nakajima K, Eguchi H, Doki Y. Kubo Y, et al. Among authors: masuike y. J Transl Med. 2022 Aug 29;20(1):383. doi: 10.1186/s12967-022-03594-2. J Transl Med. 2022. PMID: 36038893 Free PMC article.
Impact of pathological complete response following neoadjuvant chemotherapy (gemcitabine, nab-paclitaxel, S-1) and radiation for borderline resectable pancreatic cancer: a case report and review of literature.
Kinoshita M, Watanabe S, Mizojiri G, Sada A, Kai H, Masuike Y, Nagasawa Y, Maruyama K, Lee K, Ohata M, Ishikawa O, Oka H. Kinoshita M, et al. Among authors: masuike y. Surg Case Rep. 2022 Sep 14;8(1):169. doi: 10.1186/s40792-022-01529-z. Surg Case Rep. 2022. PMID: 36103018 Free PMC article.
[Squamous cell carcinoma of the anal canal showing pathological complete response after S-1 plus radiotherapy -a case report].
Hata T, Ohara N, Masuike Y, Okamoto K, Hata T, Fujino S, Yanagawa T, Kitahara T, Oshima K, Nagai K, Noda T, Miyake M, Kawanishi K, Morita S, Fujita J, Iwazawa T, Akagi K, Dono K, Kitada M. Hata T, et al. Among authors: masuike y. Gan To Kagaku Ryoho. 2011 Nov;38(12):2110-2. Gan To Kagaku Ryoho. 2011. PMID: 22202299 Review. Japanese.
Clinical Impact of Early Tumour Shrinkage in Metastatic or Unresectable Oesophageal Cancer Treated with Pembrolizumab plus Chemotherapy.
Sugase T, Kanemura T, Takeoka T, Matsuura N, Masuike Y, Shinno N, Hara H, Omori T, Kitakaze M, Kubo M, Mukai Y, Sueda T, Hasegawa S, Akita H, Nishimura J, Wada H, Yasui M, Miyata H. Sugase T, et al. Among authors: masuike y. Oncology. 2023 Dec 5. doi: 10.1159/000535186. Online ahead of print. Oncology. 2023. PMID: 38052183
Short-term Outcomes of Adjuvant Nivolumab After Neoadjuvant Chemotherapy in Patients With Resected Esophageal Squamous Cell Carcinoma.
Sugase T, Kanemura T, Takeoka T, Matsuura N, Masuike Y, Shinno N, Hara H, Kitakaze M, Kubo M, Mukai Y, Sueda T, Hasegawa S, Akita H, Nishimura J, Wada H, Yasui M, Omori T, Miyata H. Sugase T, et al. Among authors: masuike y. Anticancer Res. 2024 Jan;44(1):185-193. doi: 10.21873/anticanres.16801. Anticancer Res. 2024. PMID: 38159967
16 results